Published in

Elsevier, Journal of Experimental and Clinical Medicine, 1(40), p. 127-131, 2023

DOI: 10.52142/omujecm.40.1.27

Blood and Marrow Transplant Handbook, p. 3-9

DOI: 10.1007/978-3-319-13832-9_1

Blood and Marrow Transplant Handbook, p. 3-8

DOI: 10.1007/978-1-4419-7506-5_1

Links

Tools

Export citation

Search in Google Scholar

Overview of Hematopoietic Stem Cell Transplantation

Journal article published in 2010 by Richard T. Maziarz ORCID, Neslihan Meri̇ç
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Hematopoietic stem cell transplantation (HSCT) is the intravenous administration of hematopoietic stem cells (HSC) to restore blood cell production in individuals whose bone marrow or immune system is damaged or dysfunctional. This approach has been utilized to treat a variety of malignant and nonmalignant disorders for the past half-century. HSCT is performed in two ways, autologous and allogeneic. In the clinic, the type of stem cell transplant is decided for the patient according to the patient's diagnosis. Both types of transplantation have advantages as well as disadvantages. Knowing and managing the HSCT process well affects the success of the transplant. Knowing the complications that may occur after transplantation will facilitate the treatment process of the patient. In this short review, the HSCT process has been tried to be explained with general titles.